The U.K.'s Medicines & Healthcare Products Regulatory Agency (MHRA) granted a temporary authorization for emergency use to Pfizer and BioNTech for their COVID-19 mRNA vaccine BNT162b2 . This is the first Emergency Use Authorization following a worldwide phase III trial of a vaccine to help fight the pandemic. Like the global population, Yourway has closely followed COVID-19 vaccine trials and is excited about the beginnings of a wider rollout of the vaccine.